5 years ago

The results of a pharmacoeconomic study: incremental cost-effectiveness ratio versus net monetary benefit

To the Editor

The article by Wouters and colleagues1 presents an exhaustive overview on how quality-adjusted life years (QALYs) can be used in cost-effectiveness analysis. In this framework, the authors also mention the incremental cost-effectiveness ratio (ICER), which is the parameter typically used to express the results of a cost-effectiveness study. The article, however, does not discuss the net monetary benefit (NMB), which is another parameter used to express the results of a cost-effectiveness study.

The incremental cost (C) and the incremental effectiveness (E) are the two main parameters of pharmacoeconomics and cost-effectiveness analysis, along with the willingness-to-pay threshold (). The decision rule (eg, in the case of a favourable pharmacoeconomic result) is (C/E) < (equation 1), if based on the ICER, or (Ex–C) > 0 (equation 2), if based on the NMB. Likewise, an unfavourable pharmacoeconomic result is when (C/E) > or when...

Publisher URL: http://heart.bmj.com/cgi/content/short/103/21/1746

DOI: 10.1136/heartjnl-2017-311816

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.